Intellia Therapeutics Inc
Intellia Therapeutics Inc logo
NTLA

Intellia Therapeutics Inc (NTLA)

$58.638.55%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$52.77
Day's Range
$59.67
$37.08
52-Week Range
$180.59
1 month return19.52%
3 month return20.04%
1 year return63.51%
5 year return220.72%

Company Information

Intellia Therapeutics is a leading clinical-stage genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creating enhanced engineered cells that can treat oncological and immunological diseases. Intellia's combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts it in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create new classes of therapeutic products.
OrganizationIntellia Therapeutics Inc
Employees211
CEOJohn Leonard
IndustryHealth Technology

Analyst Recommendation

based on 28 analysts ratings

Buy
85%
Buy
14%
Hold
0%
Sell

Based on 28 Wall street analysts offering stock ratings for Intellia Therapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 174.3%

Current

$54.01

Target

$148.15

Recommendation Trend

Based on 28 analyst

Current1M Ago3M Ago
Buy
24
22
20
Hold
4
4
4
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
4.0B
Book Value
13.97
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-3.78
PEG Ratio
0.0
Wall Street Target Price
158.79

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
113.68
Price/Book (mrq)
3.64
Enterprise Value
3.1B
Enterprise Value/Revenue
94.04
Enterprise Value/Ebitda
0.0

Technicals

Beta
2.0
50 Day MA
70.83
200 Day MA
114.57

Institutional Holdings

ARK Investment Management LLC

11.84%

Vanguard Group Inc

8.43%

BlackRock Inc

7.41%

Sumitomo Mitsui Trust Holdings Inc

3.79%

FMR Inc

3.68%

Nikko Asset Management Americas Inc

3.63%

Discover more

Frequently Asked Questions

What is Intellia Therapeutics Inc share price today?

Can Indians buy Intellia Therapeutics Inc shares?

How can I buy Intellia Therapeutics Inc shares from India?

Can Fractional shares of Intellia Therapeutics Inc be purchased?

What are the documents required to start investing in Intellia Therapeutics Inc stocks?

What are today’s High and Low prices of Intellia Therapeutics Inc?

What are today’s traded volumes of Intellia Therapeutics Inc?

What is today’s market capitalisation of Intellia Therapeutics Inc?

What is the 52 Week High and Low Range of Intellia Therapeutics Inc?

How much percentage Intellia Therapeutics Inc is down from its 52 Week High?

How much percentage Intellia Therapeutics Inc is up from its 52 Week low?

What are the historical returns of Intellia Therapeutics Inc?

Who is the Chief Executive Officer (CEO) of Intellia Therapeutics Inc?